MTC provides access to FDA-approved GLP-1 weight loss injections administered under strict clinical supervision to monitor your body's response safely
Animal reproductive toxicity studies conducted with GLP-1 receptor agonists as a class have raised concerns, and human data are insufficient to establish safety
For most people taking GLP-1-based therapies including retatrutide gastrointestinal symptoms tend to be most pronounced during the early weeks of treatment and during periods of dose escalation
Does Hims & Hers meet basic legal requirements
Importantly, 100% of participants receiving the 12 mg dose achieved at least 5% weight loss, while 91% achieved 10% or greater reduction, and 75% reached the clinically significant threshold of 15% weight loss
Adicionalmente, ciertos compuestos bioactivos presentes en alimentos vegetales, como polifenoles y flavonoides, podran influir en la funcin de las clulas L segn modelos preclnicos, aunque sus efectos en humanos requieren ms investigacin